Page last updated: 2024-12-08
4-carbethoxyhexafluorobutyryl chloride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-carbethoxyhexafluorobutyryl chloride: RN from Toxlit [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 161251 |
SCHEMBL ID | 6618678 |
MeSH ID | M0173103 |
Synonyms (17)
Synonym |
---|
4-carbethoxyhexafluorobutyryl chloride |
18381-53-8 |
LS-13252 |
AKOS015836830 |
ethyl 5-chloro-2,2,3,3,4,4-hexafluoro-5-oxopentanoate |
A812820 |
ethyl hexafluoroglutaryl chloride |
pentanoic acid, 5-chloro-2,2,3,3,4,4-hexafluoro-5-oxo-, ethyl ester |
4ce-hfba |
FT-0626190 |
SCHEMBL6618678 |
DTXSID80171484 |
ethyl hexafluoroglutaryl chloride, aldrichcpr |
mfcd00054671 |
4-carboethoxyhexafluorobutyryl chloride |
ethylhexafluoroglutarylchloride |
olrxgdhrdqkngw-uhfffaoysa-n |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |